急性冠脉综合征(ACS)是属于冠心病的一种严重类型,致死率高。目前国内外针对急性冠脉综合征已发布多项指南,然而中医药对急性冠脉综合征的疗效尚缺乏重视,目前大量研究发现,中医药在急性冠脉综合征的治疗中可发挥重要的辅助作用。气虚...急性冠脉综合征(ACS)是属于冠心病的一种严重类型,致死率高。目前国内外针对急性冠脉综合征已发布多项指南,然而中医药对急性冠脉综合征的疗效尚缺乏重视,目前大量研究发现,中医药在急性冠脉综合征的治疗中可发挥重要的辅助作用。气虚血瘀证是急性冠脉综合征的一个主要证型,益气活血法在急性冠脉综合征的治疗中发挥显著疗效,可改善患者心功能、减小心肌损伤面积、抑制心室重构、降低MACE发生率。本文旨在全面深入地阐述益气活血法在急性冠脉综合征治疗中的临床疗效及其作用机制,旨在为益气活血法在ACS预防与治疗领域的进一步发展与应用提供坚实的理论基础与科学依据。Acute coronary syndrome (ACS) is a severe type of coronary heart disease with a high mortality rate. Currently, multiple guidelines for the management of ACS have been issued domestically and internationally. However, the efficacy of traditional Chinese medicine (TCM) in treating ACS has not received sufficient attention. Numerous studies have now demonstrated that TCM can play a significant adjuvant role in the treatment of ACS. Qi deficiency and blood stasis syndrome is a primary TCM syndrome type of ACS. The method of supplementing qi and activating blood circulation has shown remarkable efficacy in the treatment of ACS, improving cardiac function, reducing myocardial injury area, inhibiting ventricular remodeling, and decreasing the incidence of major adverse cardiovascular events (MACE). This paper aims to comprehensively and thoroughly elucidate the clinical efficacy and mechanism of action of the method of supplementing qi and activating blood circulation in the treatment of ACS, providing a solid theoretical foundation and scientific evidence for the further development and application of this method in the prevention and treatment of ACS.展开更多
文摘急性冠脉综合征(ACS)是属于冠心病的一种严重类型,致死率高。目前国内外针对急性冠脉综合征已发布多项指南,然而中医药对急性冠脉综合征的疗效尚缺乏重视,目前大量研究发现,中医药在急性冠脉综合征的治疗中可发挥重要的辅助作用。气虚血瘀证是急性冠脉综合征的一个主要证型,益气活血法在急性冠脉综合征的治疗中发挥显著疗效,可改善患者心功能、减小心肌损伤面积、抑制心室重构、降低MACE发生率。本文旨在全面深入地阐述益气活血法在急性冠脉综合征治疗中的临床疗效及其作用机制,旨在为益气活血法在ACS预防与治疗领域的进一步发展与应用提供坚实的理论基础与科学依据。Acute coronary syndrome (ACS) is a severe type of coronary heart disease with a high mortality rate. Currently, multiple guidelines for the management of ACS have been issued domestically and internationally. However, the efficacy of traditional Chinese medicine (TCM) in treating ACS has not received sufficient attention. Numerous studies have now demonstrated that TCM can play a significant adjuvant role in the treatment of ACS. Qi deficiency and blood stasis syndrome is a primary TCM syndrome type of ACS. The method of supplementing qi and activating blood circulation has shown remarkable efficacy in the treatment of ACS, improving cardiac function, reducing myocardial injury area, inhibiting ventricular remodeling, and decreasing the incidence of major adverse cardiovascular events (MACE). This paper aims to comprehensively and thoroughly elucidate the clinical efficacy and mechanism of action of the method of supplementing qi and activating blood circulation in the treatment of ACS, providing a solid theoretical foundation and scientific evidence for the further development and application of this method in the prevention and treatment of ACS.
